Evidence for urothelial cell activation in interstitial cystitis

Area of Science:

• Urology
• Immunology
• Cell Biology

Background:

• Interstitial cystitis (IC) is a chronic bladder condition with unknown etiology.
• Urothelial cells lining the bladder play a role in immune responses and barrier function.
• Cellular activation markers may provide insights into IC pathogenesis.

Purpose of the Study:

• To investigate urothelial cell activation in bladder biopsies from IC patients compared to controls.
• To assess the expression of specific activation markers: HLA-DR, ICAM-1, IL-1α, and TNF-α.
• To explore the potential role of urothelial cell activation in IC pathophysiology.

Main Methods:

• Bladder biopsy samples from 17 IC patients and 20 controls were analyzed.
• Immunohistochemistry using monoclonal antibodies identified expression of HLA-DR, ICAM-1, IL-1α, and TNF-α.
• In vitro studies cultured normal urothelial cells stimulated with cytokines.

Main Results:

• Significantly increased HLA-DR expression was observed in 81% of IC biopsies versus 5% in controls.
• Intercellular Adhesion Molecule 1 (ICAM-1), Interleukin-1 alpha (IL-1α), and Tumor Necrosis Factor alpha (TNF-α) expression was rare in IC patients.
• In vitro, gamma interferon and TNF-α induced ICAM-1 and HLA-DR expression on urothelial cells.

Conclusions:

• Urothelial cells in IC patients exhibit an unusual activation pattern, predominantly marked by HLA-DR.
• Defective ICAM-1 expression or differential expression of markers may indicate disease subsets or stages.
• Urothelial cell activation in IC could lead to aberrant bladder immune responses, with HLA-DR potentially serving as a diagnostic marker.